financetom
Business
financetom
/
Business
/
Atai Life Sciences Names Dr. Srinivas Rao Sole CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atai Life Sciences Names Dr. Srinivas Rao Sole CEO
Jan 10, 2025 5:43 AM

08:24 AM EST, 01/10/2025 (MT Newswires) -- Atai Life Sciences ( ATAI ) said Friday that it has appointed co-chief executive officer and co-founder Dr. Srinivas Rao as sole CEO, effective Jan. 1.

Atai Life said in May that co-CEO and co-founder Florian Brand would step down as CEO by the end of 2024.

Also on Friday, Atai Life said it has appointed Gerd Kochendoerfer as chief operating officer. Kochendoerfer previously was the chief operating officer at NFlection Therapeutics.

Shares of Atai Life Sciences ( ATAI ) were up more than 1% in recent premarket activity.

Price: 1.64, Change: +0.02, Percent Change: +1.23

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Estee Lauder Completes Acquisition of DECIEM Beauty Group
Estee Lauder Completes Acquisition of DECIEM Beauty Group
Jun 3, 2024
08:35 AM EDT, 06/03/2024 (MT Newswires) -- Estee Lauder ( EL ) said Monday it has completed its acquisition of DECIEM Beauty Group after exercising an option to purchase the remaining interests in the Canadian company for around $860 million in cash. Estee Lauder ( EL ) first invested in DECIEM in 2017 and became a majority owner in 2021....
Takeda Pharmaceutical, Pfizer Say Phase 3 Trial Assessing Blood Cancer Combination Therapy Met Co-Primary Endpoints
Takeda Pharmaceutical, Pfizer Say Phase 3 Trial Assessing Blood Cancer Combination Therapy Met Co-Primary Endpoints
Jun 3, 2024
08:37 AM EDT, 06/03/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) and Pfizer ( PFE ) said Saturday that a Phase 3 trial assessing the experimental drug Adcetris in combination with chemotherapy to treat patients with Hodgkin lymphoma, a type of blood cancer, achieved its co-primary endpoints at a preplanned three-year analysis. The study group demonstrated superior progression-free survival...
NXT Energy Says MCAPM LP To Increase Stake With Debentures Buy and Provides Management Update
NXT Energy Says MCAPM LP To Increase Stake With Debentures Buy and Provides Management Update
Jun 3, 2024
08:35 AM EDT, 06/03/2024 (MT Newswires) -- NXT Energy Solutions ( NSFDF ) on Monday said it is raising US$2 million in a fully subscribed offering of convertible debentures. The Toronto Stock Exchange has provided conditional approval of the private placement, it noted. The oilfield-services company said the two-year debentures, which carry a 10% interest rate and can be converted...
Spirit Airlines names Brian McMenamy as interim CFO
Spirit Airlines names Brian McMenamy as interim CFO
Jun 3, 2024
June 3 (Reuters) - Spirit Airlines ( SAVE ) on Monday named Brian McMenamy as interim chief financial officer, effective June 14. McMenamy, currently vice president and controller, takes over from Scott Haralson who is departing to become finance chief of a company outside of the airline industry. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved